Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Abstrakt

Advances in Kidney Cancer Diagnosis: Current Approaches and Future Perspectives

Hamid Saeedi*

Kidney cancer, also known as renal cell carcinoma (RCC), is a prevalent urological malignancy with substantial morbidity and mortality. Timely and accurate diagnosis is essential for effective treatment and improved patient outcomes. Recent advancements in diagnostic approaches, including imaging modalities, biomarker discovery, liquid biopsy, molecular profiling, and artificial intelligence, have revolutionized kidney cancer diagnosis. This research article provides a comprehensive overview of the current state of kidney cancer diagnosis and explores the potential future perspectives. It discusses traditional and advanced diagnostic methods, the role of biomarkers, and the promise of liquid biopsy in non-invasive diagnosis. Furthermore, it highlights the contribution of genomic analysis and artificial intelligence in improving diagnostic accuracy. Integrative diagnostic approaches are also examined, which amalgamate multiple diagnostic modalities for better patient management. With a deeper understanding of kidney cancer’s molecular basis, innovative diagnostic technologies hold the potential to enhance early detection rates and pave the way for personalized treatment strategies.